Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|8|1123-1129

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.8, 2012-10, pp. : 1123-1129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1699-1713

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 21, Iss. 42, 2015-12 ,pp. : 6070-6080

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 31, 2010-10 ,pp. : 3442-3454

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases

By Broadley K.J.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1669-1692

Informa Healthcare

Access to resources Recommend Favorite

Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 17, 2007-06 ,pp. : 1741-1750

Bentham Science Publishers

Access to resources Recommend Favorite